TransMedics
TMDX
85.25
-8.77
-9.33%
TransMedics
US · TMDX
#2536 by market cap
Listed 2019
85.25
-8.77
-9.33%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About TransMedics
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
- Founded
- 1998
- CEO
- Dr. Waleed H. Hassanein, M.D.
- Employees
- 898
- Headquarters
- Andover, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- transmedics.com
Company profile
- Exchange
- US
- Symbol
- TMDX
- Market-cap rank
- #2536
- Listing date
- 2019-05-02
- Market cap
- 2.96B
- Float cap
- 2.87B
- Shares out
- 34.73M
- Float shares
- 33.62M
Sectors & themes
Medical Devices
Fractional Shares JP
Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.
TransMedics discussion 0 comments